Passage Bio Stock Probability of Future Stock Price Finishing Over 34.26
| PASG Stock | USD 0.76 0.02 2.56% |
Passage |
Passage Bio Target Price Odds to finish over 34.26
The tendency of Passage Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 34.26 or more in 90 days |
| 0.76 | 90 days | 34.26 | close to zero percent |
Based on a normal probability distribution, the odds of Passage Bio to move over $ 34.26 or more in 90 days from now is close to zero percent (This Passage Bio probability density function shows the probability of Passage Stock to fall within a particular range of prices over 90 days) . Probability of Passage Bio price to stay between its current price of $ 0.76 and $ 34.26 at the end of the 90-day period is about 18.16 .
Given the investment horizon of 90 days the stock has the beta coefficient of 3.35 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Passage Bio will likely underperform. Additionally Passage Bio has an alpha of 0.2073, implying that it can generate a 0.21 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Passage Bio Price Density |
| Price |
Predictive Modules for Passage Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Passage Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Passage Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Passage Bio Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Passage Bio is not an exception. The market had few large corrections towards the Passage Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Passage Bio, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Passage Bio within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.21 | |
β | Beta against Dow Jones | 3.35 | |
σ | Overall volatility | 0.11 | |
Ir | Information ratio | 0.04 |
Passage Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Passage Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Passage Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Passage Bio is way too risky over 90 days horizon | |
| Passage Bio has some characteristics of a very speculative penny stock | |
| Passage Bio appears to be risky and price may revert if volatility continues | |
| Passage Bio has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (102.06 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Passage Bio currently holds about 239.25 M in cash with (78.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.39, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Passage Bio has a frail financial position based on the latest SEC disclosures | |
| Roughly 60.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Passage Bio, Inc. Major Shareholder Sells 54,181 Shares |
Passage Bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Passage Stock often depends not only on the future outlook of the current and potential Passage Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Passage Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 54.7 M | |
| Cash And Short Term Investments | 114.3 M |
Passage Bio Technical Analysis
Passage Bio's future price can be derived by breaking down and analyzing its technical indicators over time. Passage Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Passage Bio. In general, you should focus on analyzing Passage Stock price patterns and their correlations with different microeconomic environments and drivers.
Passage Bio Predictive Forecast Models
Passage Bio's time-series forecasting models is one of many Passage Bio's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Passage Bio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Passage Bio
Checking the ongoing alerts about Passage Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Passage Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Passage Bio is way too risky over 90 days horizon | |
| Passage Bio has some characteristics of a very speculative penny stock | |
| Passage Bio appears to be risky and price may revert if volatility continues | |
| Passage Bio has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (102.06 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Passage Bio currently holds about 239.25 M in cash with (78.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.39, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Passage Bio has a frail financial position based on the latest SEC disclosures | |
| Roughly 60.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Passage Bio, Inc. Major Shareholder Sells 54,181 Shares |
Check out Passage Bio Backtesting, Passage Bio Valuation, Passage Bio Correlation, Passage Bio Hype Analysis, Passage Bio Volatility, Passage Bio History as well as Passage Bio Performance. For more detail on how to invest in Passage Stock please use our How to Invest in Passage Bio guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Passage Bio. If investors know Passage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Passage Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.17) | Return On Assets (0.34) | Return On Equity (0.64) |
The market value of Passage Bio is measured differently than its book value, which is the value of Passage that is recorded on the company's balance sheet. Investors also form their own opinion of Passage Bio's value that differs from its market value or its book value, called intrinsic value, which is Passage Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Passage Bio's market value can be influenced by many factors that don't directly affect Passage Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Passage Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Passage Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Passage Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.